Enhanced ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin
Abstract
Herein, we systematically and quantitatively evaluate whether endoplasmic reticulum (ER) proteostasis factors impact the mutational tolerance of secretory pathway proteins. We focus on influenza hemagluttinin (HA), a viral membrane protein that folds in the host's ER via a complex pathway. By integrating chemical methods to modulate ER proteostasis with deep mutational scanning to assess mutational tolerance, we discover that upregulation of ER proteostasis factors broadly enhances HA mutational tolerance across diverse structural elements. Remarkably, this proteostasis network-enhanced mutational tolerance occurs at the same sites where mutational tolerance is most reduced by propagation at fever-like temperature. These findings have important implications for influenza evolution, because influenza immune escape is contingent on HA possessing sufficient mutational tolerance to evade antibodies while maintaining the capacity to fold and function. More broadly, this work provides the first experimental evidence that ER proteostasis mechanisms define the mutational tolerance and, therefore, the evolution of secretory pathway proteins.
Data availability
FASTQ files for DMS sequencing are available in the Sequence Read Archive under accession number SRP149672. The deep mutational scanning data analysis will be available upon publication at https://github.com/amphilli/HA_DMS_2018, and is also available in Dataset 1. All differential selection values from deep mutational scanning (pre- and post-filtering) are available in Figure 5-source data 1. The complete RNAseq data are available from GEO under accession number GSE115168.
-
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutininPublicly available at the NCBI Gene Expression Omnibus (accession no: GSE115168).
Article and author information
Author details
Funding
National Science Foundation (CAREER Award 1652390)
- Matthew D Shoulders
National Science Foundation (Graduate Research Fellowship)
- Angela M Phillips
Richard and Susan Smith Family Foundation (Award for Excellence in Biomedical Research)
- Matthew D Shoulders
Massachusetts Institute of Technology
- Matthew D Shoulders
Tufts University
- Yu-Shan Lin
National Cancer Institute (Koch Institute Support (core) Grant P30-CA14051)
- Vincent L Butty
- Matthew D Shoulders
National Institutes of Health (Al127893)
- Jesse D Bloom
Howard Hughes Medical Institute (Faculty Scholars grant)
- Jesse D Bloom
Simons Foundation (Faculty Scholars grant)
- Jesse D Bloom
National Institute of Environmental Health Sciences (MIT Center for Environmental Health Sciences (core) Grant P30-ES002109)
- Vincent L Butty
- Matthew D Shoulders
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2018, Phillips et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,537
- views
-
- 399
- downloads
-
- 27
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Stem Cells and Regenerative Medicine
Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors and find that while they express a near-identical set of proteins, they show consistent quantitative differences in the abundance of a subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs, with increased abundance of cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins. Prominent changes detected in proteins involved in mitochondrial metabolism correlated with enhanced mitochondrial potential, shown using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including growth factors and proteins involved in the inhibition of the immune system. The data indicate that reprogramming of fibroblasts to hiPSCs produces important differences in cytoplasmic and mitochondrial proteins compared to hESCs, with consequences affecting growth and metabolism. This study improves our understanding of the molecular differences between hiPSCs and hESCs, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.